Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions are supporting biopharma companies around the world to develop and produce drugs safely, timely and economically. To meet the rapidly changing technology requirements of the industry it serves, Sartorius Stedim Biotech focuses on single-use technologies and value-added services.
DRUG SUBSTANCES AND REAGENTS
API Process Capabilities
API Related Services
- (21.07.2017) Solid Growth at Sartorius Stedim Biotech; Profits Continue to Rise
- (04.05.2017) Sartorius Stedim Biotech Launches Chemistry Testing Services
- (24.04.2017) First-Quarter Figures: Sartorius Stedim Biotech Off to a Good Start in 2017
- (03.04.2017) Sartorius Stedim Biotech (SSB) Acquires Leading Biopharma Software Developer Umetrics
- (03.03.2017) Sartorius to Acquire Real-Time Live-Cell Analysis Pioneer and Leader Essen BioScience
- (30.01.2017) 2016 Targets Fully Achieved; Strong Outlook for 2017
- (10.11.2016) Sartorius Stedim Biotech Opens New Bioanalytical Testing Laboratory
- (17.04.2015) Sartorius Stedim Biotech Acquires UK-based CRO, BioOutsource
- (14.04.2015) Sartorius: Supplementary Information on 2014 Business Figures
- (19.12.2014) Sartorius to Sell Its Industrial Technologies Division to Minebea Co., Ltd.
- (28.04.2014) Sartorius Stedim Biotech Acquires Majority Stake In U.S. Start-Up AllPure Technologies
- (01.07.2013) Sartorius Postpones Sale of Industrial Weighing Division
- (15.04.2013) Sartorius Stedim Biotech: Fact Sheet on New Reporting Format
- (11.03.2013) Sartorius Reviews Fiscal 2012
- (03.06.2008) Sartorius Stedim Biotech Signs Agreement With WuXi AppTec, Inc.